IFNB1 and Erythema: These inhibitors protracted the erythema regression (Fig. 8f–h) and duration times (Supplementary Fig. 12f), and increased the cGAMP (Supplementary Fig. 12g) and Ifnb (Supplementary Fig. 12h, i) production.